Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001673368-17-000001
Filing Date
2017-05-12
Accepted
2017-05-12 12:14:00
Documents
1
Effectiveness Date
2017-05-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13284
  Complete submission text file 0001673368-17-000001.txt   14929
Mailing Address 400 S. EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402
Business Address 400 S. EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 650-401-2000
DalCor Pharmaceuticals US, LLC (Filer) CIK: 0001673368 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-263148 | Film No.: 17837362

Mailing Address 1010 SHERBROOKE ST. WEST, SUITE 408 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST. WEST, SUITE 408 MONTREAL A8 H3A 2R7 514-564-6474
DalCor Pharmaceuticals Canada Inc. (Filer) CIK: 0001673372 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-263148-01 | Film No.: 17837361